Autonomic Modulation in Takotsubo Syndrome



Status:Not yet recruiting
Healthy:No
Age Range:21 - Any
Updated:2/2/2019
Start Date:March 2019
End Date:December 2019
Contact:Harmony Reynolds
Email:brokenheartstudy@nyumc.org
Phone:646-501-0302

Use our guide to learn which trials are right for you!

This is a minimal risk case-controlled single arm intervention study, including 10 patients
with a prior history of takotsubo and 10-age and sex matched healthy controls. Subjects will
undergo in laboratory testing to measure autonomic function. They will then undergo a 15-week
program of device-guided breathing with remote measures of autonomic function obtained at
home. Analysis will determine the reproducibility of home autonomic measures and the provide
preliminary data to determine the efficacy of device-guided breathing on autonomic measures
and quality of life in patients with takotsubo.


Inclusion Criteria:

- Confirmed history of takotsubo syndrome

- Healthy person with no significant past history of cardiovascular or neurological
disease such as heart failure or heart attack; people with cardiovascular risk factors
such as hypertension will be permitted to participate

Exclusion Criteria:

- Pacemaker or defibrillator implanted

- Evidence of autonomic neuropathy, alcohol or drug abuse or exposure to neurotoxins
(chemotherapy).

- Diabetes
We found this trial at
1
site
550 1st Ave
New York, New York 10016
(212) 263-7300
Principal Investigator: Harmony Reynolds, MD
Phone: 646-501-0302
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials